JPMorgan Steps Aside From China Deal, Fearing Regulatory Scrutiny – ValueWalk Premium
JPMorgan

JPMorgan Steps Aside From China Deal, Fearing Regulatory Scrutiny

JPMorgan Chase & Co. (NYSE:JPM) has stepped aside on a Chinese firm’s initial public offering amid investigations by U.S. regulators into its hiring practices in China.

The bank’s latest move to pull out from Tianhe Chemicals’ IPO follows its decision to exit from two more deals earlier.
Probe into JPMorgan’s hiring practice in China

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0